Perspective: At the Cusp of Gridlock - Data Overload Driving Database Appliance Adoption

This IDC Health Insights Perspective highlights early evidence supporting the adoption of database appliances and related engineered systems by the pharmaceutical industry. As an industry overwhelmed by an abundance of data, the growth of particular data and the need to more effectively mine and exploit data in a timely fashion are beginning to drive significant investment in this area. With their ability to routinely perform rapid analyses on massively large data sets, these solution platforms provide the ability to deliver timely results from queries and more complex analyses in instances where traditional IT can fail to perform.

As expected, specific data-intensive applications are driving early database appliance and related engineered systems adoption within pharma. Collectively, these applications, with their focus on delivering actionable insights, impact all levels of the organization ranging from bench scientists to the C-suite. While the near-term benefits of transitioning specific applications to a dedicated database solution platform are easy to identify, it is likely too early to establish a quantifiable ROI at this early stage of adoption.